Clinical Trial Update: Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS [Phase 4]

View source ↗

Summary

A phase 4 trial comparing continuous infusion versus intermittent boluses of cisatracurium in pediatric ARDS to optimize early management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury Acute Respiratory Distress Syndrome
• Respiratory Distress Syndrome Pediatric

Drugs mentioned

• Cisatracurium (Cisatracurium besylate)

Snippet

Sponsor: Tanta University | Conditions: Respiratory Distress Syndrome, Pediatric, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Phase 4 | Status: UNKNOWN